ArticleThe Journal of urology2026

Urine Tumor DNA Testing Identifies Recurrence and Monitors Therapy Response in Patients With High-Risk Nonmuscle-Invasive Bladder Cancer Receiving Intravesical Bacillus Calmette-Guérin.

Henning Bahlburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.